Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ecleralimab (CSJ-117; NVP-CSJ117), a Fab-IgG1-λ2 monoclonal antibody, selectively targets thymic stromal lymphopoietin (TSLP). It is typically produced using a Chinese Hamster Ovary (CHO) cell expression system [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Ecleralimab (CSJ-117; NVP-CSJ117), a Fab-IgG1-λ2 monoclonal antibody, selectively targets thymic stromal lymphopoietin (TSLP). It is typically produced using a Chinese Hamster Ovary (CHO) cell expression system [1]. |
Synonyms | CSJ-117, NVP-CSJ117 |
Molecular Weight | N/A |
CAS No. | 2415207-91-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ecleralimab 2415207-91-7 CSJ-117 NVP-CSJ117 inhibitor inhibit